169 related articles for article (PubMed ID: 34904328)
1. Quantitative evaluation of brain iron accumulation in different stages of Parkinson's disease.
Li KR; Avecillas-Chasin J; Nguyen TD; Gillen KM; Dimov A; Chang E; Skudin C; Kopell BH; Wang Y; Shtilbans A
J Neuroimaging; 2022 Mar; 32(2):363-371. PubMed ID: 34904328
[TBL] [Abstract][Full Text] [Related]
2. Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.
An H; Zeng X; Niu T; Li G; Yang J; Zheng L; Zhou W; Liu H; Zhang M; Huang D; Li J
J Neurol Sci; 2018 Mar; 386():46-52. PubMed ID: 29406966
[TBL] [Abstract][Full Text] [Related]
3. Region-specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mapping.
He N; Ling H; Ding B; Huang J; Zhang Y; Zhang Z; Liu C; Chen K; Yan F
Hum Brain Mapp; 2015 Nov; 36(11):4407-20. PubMed ID: 26249218
[TBL] [Abstract][Full Text] [Related]
4. Regionally progressive accumulation of iron in Parkinson's disease as measured by quantitative susceptibility mapping.
Guan X; Xuan M; Gu Q; Huang P; Liu C; Wang N; Xu X; Luo W; Zhang M
NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 26853890
[TBL] [Abstract][Full Text] [Related]
5. Iron deposition in Parkinson's disease by quantitative susceptibility mapping.
Chen Q; Chen Y; Zhang Y; Wang F; Yu H; Zhang C; Jiang Z; Luo W
BMC Neurosci; 2019 May; 20(1):23. PubMed ID: 31117957
[TBL] [Abstract][Full Text] [Related]
6. Utility of quantitative susceptibility mapping and diffusion kurtosis imaging in the diagnosis of early Parkinson's disease.
Tan S; Hartono S; Welton T; Ann CN; Lim SL; Koh TS; Li H; Setiawan F; Ng S; Chia N; Liu S; Mark Haacke E; King Tan E; Chew Seng Tan L; Ling Chan L
Neuroimage Clin; 2021; 32():102831. PubMed ID: 34619654
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of iron deposition in brain basal ganglia of patients with Parkinson's disease using quantitative susceptibility mapping.
Shahmaei V; Faeghi F; Mohammdbeigi A; Hashemi H; Ashrafi F
Eur J Radiol Open; 2019; 6():169-174. PubMed ID: 31065578
[TBL] [Abstract][Full Text] [Related]
8. Quantitative Susceptibility Mapping in Parkinson's Disease.
Langkammer C; Pirpamer L; Seiler S; Deistung A; Schweser F; Franthal S; Homayoon N; Katschnig-Winter P; Koegl-Wallner M; Pendl T; Stoegerer EM; Wenzel K; Fazekas F; Ropele S; Reichenbach JR; Schmidt R; Schwingenschuh P
PLoS One; 2016; 11(9):e0162460. PubMed ID: 27598250
[TBL] [Abstract][Full Text] [Related]
9. Combined Application of Quantitative Susceptibility Mapping and Diffusion Kurtosis Imaging Techniques to Investigate the Effect of Iron Deposition on Microstructural Changes in the Brain in Parkinson's Disease.
Yang L; Cheng Y; Sun Y; Xuan Y; Niu J; Guan J; Rong Y; Jia Y; Zhuang Z; Yan G; Wu R
Front Aging Neurosci; 2022; 14():792778. PubMed ID: 35370619
[TBL] [Abstract][Full Text] [Related]
10. Spatiotemporal patterns of brain iron-oxygen metabolism in patients with Parkinson's disease.
Yan S; Lu J; Li Y; Cho J; Zhang S; Zhu W; Wang Y
Eur Radiol; 2024 May; 34(5):3074-3083. PubMed ID: 37853173
[TBL] [Abstract][Full Text] [Related]
11. Quantitative assessment of iron deposition in the midbrain using 3D-enhanced T2 star weighted angiography (ESWAN): a preliminary cross-sectional study of 20 Parkinson's disease patients.
Wang C; Fan G; Xu K; Wang S
Magn Reson Imaging; 2013 Sep; 31(7):1068-73. PubMed ID: 23746648
[TBL] [Abstract][Full Text] [Related]
12. Histogram Analysis of Quantitative Susceptibility Mapping for the Diagnosis of Parkinson's Disease.
Zhang Y; Yang M; Wang F; Chen Y; Liu R; Zhang Z; Jiang Z
Acad Radiol; 2022 Mar; 29 Suppl 3():S71-S79. PubMed ID: 33189552
[TBL] [Abstract][Full Text] [Related]
13. Time-Specific Pattern of Iron Deposition in Different Regions in Parkinson's Disease Measured by Quantitative Susceptibility Mapping.
Fu X; Deng W; Cui X; Zhou X; Song W; Pan M; Chi X; Xu J; Jiang Y; Wang Q; Xu Y
Front Neurol; 2021; 12():631210. PubMed ID: 34421781
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of QSM over R2* in assessment of parkinson's disease - A systematic review.
Saikiran P;
Neurol India; 2020; 68(2):278-281. PubMed ID: 32415005
[TBL] [Abstract][Full Text] [Related]
15. Analyzing the co-localization of substantia nigra hyper-echogenicities and iron accumulation in Parkinson's disease: A multi-modal atlas study with transcranial ultrasound and MRI.
Ahmadi SA; Bötzel K; Levin J; Maiostre J; Klein T; Wein W; Rozanski V; Dietrich O; Ertl-Wagner B; Navab N; Plate A
Neuroimage Clin; 2020; 26():102185. PubMed ID: 32050136
[TBL] [Abstract][Full Text] [Related]
16. Combination of Quantitative Susceptibility Mapping and Diffusion Kurtosis Imaging Provides Potential Biomarkers for Early-Stage Parkinson's Disease.
Rong Y; Xu Z; Zhu Y; Zhang X; Lai L; Sun S; Gao M; Guo P; Zhang G; Geng Y; Ma X; Wu S; Yang L; Shen Z; Guan J
ACS Chem Neurosci; 2022 Sep; 13(18):2699-2708. PubMed ID: 36047877
[No Abstract] [Full Text] [Related]
17. Assessment of cerebral iron content in patients with Parkinson's disease by the susceptibility-weighted MRI.
Wu SF; Zhu ZF; Kong Y; Zhang HP; Zhou GQ; Jiang QT; Meng XP
Eur Rev Med Pharmacol Sci; 2014; 18(18):2605-8. PubMed ID: 25317792
[TBL] [Abstract][Full Text] [Related]
18. Motor associations of iron accumulation in deep grey matter nuclei in Parkinson's disease: a cross-sectional study of iron-related magnetic resonance imaging susceptibility.
Martin-Bastida A; Lao-Kaim NP; Loane C; Politis M; Roussakis AA; Valle-Guzman N; Kefalopoulou Z; Paul-Visse G; Widner H; Xing Y; Schwarz ST; Auer DP; Foltynie T; Barker RA; Piccini P
Eur J Neurol; 2017 Feb; 24(2):357-365. PubMed ID: 27982501
[TBL] [Abstract][Full Text] [Related]
19. Quantitative susceptibility mapping in atypical Parkinsonisms.
Mazzucchi S; Frosini D; Costagli M; Del Prete E; Donatelli G; Cecchi P; Migaleddu G; Bonuccelli U; Ceravolo R; Cosottini M
Neuroimage Clin; 2019; 24():101999. PubMed ID: 31539801
[TBL] [Abstract][Full Text] [Related]
20. Free water and iron content in the substantia nigra at different stages of Parkinson's disease.
Chen M; Wang Y; Zhang C; Li J; Li Z; Guan X; Bao J; Zhang Y; Cheng J; Wei H
Eur J Radiol; 2023 Oct; 167():111030. PubMed ID: 37579561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
